daunorubicin has been researched along with Lung Diseases, Interstitial in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, T; Huang, L; Jiang, Y; Peng, H; Shen, Q; Thapa, S; Yang, K; Yu, S; Zhang, L; Zhou, T | 1 |
1 other study(ies) available for daunorubicin and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Incidence of interstitial pneumonitis in non-Hodgkin's lymphoma patients receiving immunochemotherapy with pegylated liposomal doxorubicin and rituximab.
Topics: Adult; Aged; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubicin; Doxorubicin; Female; Humans; Immunotherapy; Incidence; Lung Diseases, Interstitial; Lymphoma, Non-Hodgkin; Male; Middle Aged; Polyethylene Glycols; Prednisone; Retrospective Studies; Rituximab; Vincristine | 2018 |